Cargando…
Treatment and Prognosis of Oral Cancer Patients with Confirmed Contralateral Neck Metastasis: A Multicenter Retrospective Analysis
The prognosis of oral cancer that has metastasized to the contralateral cervical lymph nodes is poor, although the appropriate treatment method has not been established because of its rarity. A multicenter retrospective study on the treatment and prognosis of pN2c oral cancer patients was conducted....
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368347/ https://www.ncbi.nlm.nih.gov/pubmed/35954583 http://dx.doi.org/10.3390/ijerph19159229 |
_version_ | 1784766099193069568 |
---|---|
author | Sakamoto, Yuki Otsuru, Mitsunobu Hasegawa, Takumi Akashi, Masaya Yamada, Shin-ichi Kurita, Hiroshi Okura, Masaya Yamakawa, Nobuhiro Kirita, Tadaaki Yanamoto, Souichi Umeda, Masahiro Kojima, Yuka |
author_facet | Sakamoto, Yuki Otsuru, Mitsunobu Hasegawa, Takumi Akashi, Masaya Yamada, Shin-ichi Kurita, Hiroshi Okura, Masaya Yamakawa, Nobuhiro Kirita, Tadaaki Yanamoto, Souichi Umeda, Masahiro Kojima, Yuka |
author_sort | Sakamoto, Yuki |
collection | PubMed |
description | The prognosis of oral cancer that has metastasized to the contralateral cervical lymph nodes is poor, although the appropriate treatment method has not been established because of its rarity. A multicenter retrospective study on the treatment and prognosis of pN2c oral cancer patients was conducted. We investigated the treatment and prognosis of 62 pN2c patients out of 388 pN+ patients with oral squamous cell carcinomas. Statistical analysis was performed on the various factors with overall survival (OS) and disease specific survival (DSS). In multivariate cox regression analysis, advanced T stage was significantly correlated with poor OS (p = 0.011) and DSS (p = 0.023) of patients with pN2c neck. In pN2c patients, OS, DSS, and neck control was not different between those undergoing ipsilateral neck dissection initially and those undergoing bilateral neck dissection. Thus, contralateral elective neck dissection is not recommended. The most important risk factor for prognosis in pN2c oral cancer patients is advanced T stage. No evidence was found to recommend contralateral elective neck dissection in clinically N1/2b patients. Therefore, the indication for contralateral elective neck dissection in N1/2b patients should be carefully determined in consideration of individual conditions. |
format | Online Article Text |
id | pubmed-9368347 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93683472022-08-12 Treatment and Prognosis of Oral Cancer Patients with Confirmed Contralateral Neck Metastasis: A Multicenter Retrospective Analysis Sakamoto, Yuki Otsuru, Mitsunobu Hasegawa, Takumi Akashi, Masaya Yamada, Shin-ichi Kurita, Hiroshi Okura, Masaya Yamakawa, Nobuhiro Kirita, Tadaaki Yanamoto, Souichi Umeda, Masahiro Kojima, Yuka Int J Environ Res Public Health Article The prognosis of oral cancer that has metastasized to the contralateral cervical lymph nodes is poor, although the appropriate treatment method has not been established because of its rarity. A multicenter retrospective study on the treatment and prognosis of pN2c oral cancer patients was conducted. We investigated the treatment and prognosis of 62 pN2c patients out of 388 pN+ patients with oral squamous cell carcinomas. Statistical analysis was performed on the various factors with overall survival (OS) and disease specific survival (DSS). In multivariate cox regression analysis, advanced T stage was significantly correlated with poor OS (p = 0.011) and DSS (p = 0.023) of patients with pN2c neck. In pN2c patients, OS, DSS, and neck control was not different between those undergoing ipsilateral neck dissection initially and those undergoing bilateral neck dissection. Thus, contralateral elective neck dissection is not recommended. The most important risk factor for prognosis in pN2c oral cancer patients is advanced T stage. No evidence was found to recommend contralateral elective neck dissection in clinically N1/2b patients. Therefore, the indication for contralateral elective neck dissection in N1/2b patients should be carefully determined in consideration of individual conditions. MDPI 2022-07-28 /pmc/articles/PMC9368347/ /pubmed/35954583 http://dx.doi.org/10.3390/ijerph19159229 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Sakamoto, Yuki Otsuru, Mitsunobu Hasegawa, Takumi Akashi, Masaya Yamada, Shin-ichi Kurita, Hiroshi Okura, Masaya Yamakawa, Nobuhiro Kirita, Tadaaki Yanamoto, Souichi Umeda, Masahiro Kojima, Yuka Treatment and Prognosis of Oral Cancer Patients with Confirmed Contralateral Neck Metastasis: A Multicenter Retrospective Analysis |
title | Treatment and Prognosis of Oral Cancer Patients with Confirmed Contralateral Neck Metastasis: A Multicenter Retrospective Analysis |
title_full | Treatment and Prognosis of Oral Cancer Patients with Confirmed Contralateral Neck Metastasis: A Multicenter Retrospective Analysis |
title_fullStr | Treatment and Prognosis of Oral Cancer Patients with Confirmed Contralateral Neck Metastasis: A Multicenter Retrospective Analysis |
title_full_unstemmed | Treatment and Prognosis of Oral Cancer Patients with Confirmed Contralateral Neck Metastasis: A Multicenter Retrospective Analysis |
title_short | Treatment and Prognosis of Oral Cancer Patients with Confirmed Contralateral Neck Metastasis: A Multicenter Retrospective Analysis |
title_sort | treatment and prognosis of oral cancer patients with confirmed contralateral neck metastasis: a multicenter retrospective analysis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368347/ https://www.ncbi.nlm.nih.gov/pubmed/35954583 http://dx.doi.org/10.3390/ijerph19159229 |
work_keys_str_mv | AT sakamotoyuki treatmentandprognosisoforalcancerpatientswithconfirmedcontralateralneckmetastasisamulticenterretrospectiveanalysis AT otsurumitsunobu treatmentandprognosisoforalcancerpatientswithconfirmedcontralateralneckmetastasisamulticenterretrospectiveanalysis AT hasegawatakumi treatmentandprognosisoforalcancerpatientswithconfirmedcontralateralneckmetastasisamulticenterretrospectiveanalysis AT akashimasaya treatmentandprognosisoforalcancerpatientswithconfirmedcontralateralneckmetastasisamulticenterretrospectiveanalysis AT yamadashinichi treatmentandprognosisoforalcancerpatientswithconfirmedcontralateralneckmetastasisamulticenterretrospectiveanalysis AT kuritahiroshi treatmentandprognosisoforalcancerpatientswithconfirmedcontralateralneckmetastasisamulticenterretrospectiveanalysis AT okuramasaya treatmentandprognosisoforalcancerpatientswithconfirmedcontralateralneckmetastasisamulticenterretrospectiveanalysis AT yamakawanobuhiro treatmentandprognosisoforalcancerpatientswithconfirmedcontralateralneckmetastasisamulticenterretrospectiveanalysis AT kiritatadaaki treatmentandprognosisoforalcancerpatientswithconfirmedcontralateralneckmetastasisamulticenterretrospectiveanalysis AT yanamotosouichi treatmentandprognosisoforalcancerpatientswithconfirmedcontralateralneckmetastasisamulticenterretrospectiveanalysis AT umedamasahiro treatmentandprognosisoforalcancerpatientswithconfirmedcontralateralneckmetastasisamulticenterretrospectiveanalysis AT kojimayuka treatmentandprognosisoforalcancerpatientswithconfirmedcontralateralneckmetastasisamulticenterretrospectiveanalysis |